Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date

Fletcher L, Joshi SK, Traer E

Cancer Management and Research 2020, 12:151-163

Published Date: 8 January 2020